Pazopanib Tablet, Film Coated
Product Images NDC 59651-582

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pazopanib (NDC 59651-582). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Pazopanib Fig1)

A Kaplan-Meier curve depicting the proportion of patients progression-free over time (months) comparing Pazopanib (N=290) and placebo (N=145). The graph shows higher progression-free survival for Pazopanib with a median of 9.2 months versus 4.2 months for placebo. Hazard ratio 0.46 with 95% confidence interval 0.34 to 0.62, and p-value less than 0.001.*

FDA Label Image

Figure-2 (Pazopanib Fig2)

A Kaplan-Meier survival curve graph depicting the proportion of patients progression-free over time in months. The solid line represents patients treated with Pazopanib (N=246), showing a median progression-free period of 4.6 months, while the dashed line represents the placebo group (N=123) with a median of 1.6 months. Statistical data including hazard ratio, confidence interval, and p-value are also presented.*

FDA Label Image

Pazopanib-fig3 (Pazopanib Fig3)

Label for Pazopanib Tablets 200 mg, film-coated oral tablets, with a 30-tablet package size. Distributed by Aurobindo Pharma USA, Inc., labeled with NDC 59651-582-30. The label includes storage instructions, dosage information reference, and a barcode on the right side.*

FDA Label Image

Pazopanib-fig4 (Pazopanib Fig4)

Label for Pazopanib Tablets 200 mg, film-coated oral tablets. The label indicates a package count of 90 tablets. It includes the NDC 59651-582-90, storage instructions, and manufacturer information for Aurobindo Pharma USA, Inc., with manufacturing origin noted as India. The label also provides medication guide and dispensing instructions.*

FDA Label Image

Pazopanib-fig5 (Pazopanib Fig5)

Label for Pazopanib Tablets 200 mg film-coated tablets, oral use, supplied in a package of 120 tablets. The label shows the National Drug Code (NDC) 59651-582-08, the distributor Aurobindo Pharma USA, Inc., and notes the medication is made in India by Aurobindo Pharma Limited. Storage instructions and a reminder to dispense the Medication Guide are also included.*

FDA Label Image

Checmical-structure (Pazopanib Str)

Chemical structure of Pazopanib shown as a molecular formula diagram including aromatic rings, methyl groups, nitrogen-containing heterocycles, and a sulfonamide moiety with HCl indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.